If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Director/PDMR Shareholding

24 Oct 2019 14:30

RNS Number : 0641R
Reckitt Benckiser Group PLC
24 October 2019
 

 

24 October 2019

 

RECKITT BENCKISER GROUP PLC

 DIRECTOR/PDMR SHAREHOLDINGS

 

 

Reckitt Benckiser Group plc (the "Company" or "RB") announces the following change in the interests of a Director in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

 

The Company was notified on 23 October 2019 that Sara Mathew, Non-Executive Director, purchased a total of 378 American Depositary Receipts in the Company (ADRs) on 23 October 2019 at a price of $15.46 each. Five ADRs represent one Share.

 

The remuneration of RB's Non-Executive Directors includes fees which are to be used in the purchase of Shares or equivalent, e.g. ADRs. £16,750 of the Non-Executive Directors' base fee (net) is invested in Shares or equivalent which they are expected to retain for the duration of their tenure. The amount of Sara Mathew's fees applied in this way were pro-rated based on her appointment to the Board on 1 July 2019.  

 

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sara Mathew

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

American Depositary Receipts (each American Depositary Receipt is equivalent to five Ordinary shares of 10 pence each in Reckitt Benckiser Group PLC)

GB00B24CGK77

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

$15.46

378

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregate Price

Aggregate Volume

Aggregate Total

$15.46

378

$5843.88

 

e)

Date of the transaction

2019-10-23

f)

Place of the transaction

United States (OTC)

 

 

 

 

For further Information:Christine Logan

Deputy Company SecretaryTel +44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations

Tel. +44 (0)1753 217 800

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

About RB

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes.

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide.

For more information visit www.rb.com

 

 *RB is the trading name of the Reckitt Benckiser group of companies

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBXBDGRDDBGCS
Date   Source Headline
5th Mar 20194:30 pmRNSDirector Declaration
4th Mar 201911:43 amRNSDirector/PDMR Shareholding
1st Mar 20197:30 amRNSTotal Voting Rights
28th Feb 201911:16 amRNSDirector/PDMR Shareholding
20th Feb 20193:19 pmRNSDirector/PDMR Shareholding
18th Feb 20197:00 amRNSFull Year Results 2018
1st Feb 20198:44 amRNSTotal Voting Rights
16th Jan 20197:05 amRNSRakesh Kapoor to retire as CEO by end of 2019
4th Jan 201911:00 amRNSDirectorate Change
2nd Jan 20192:23 pmRNSDirectorate Change
31st Dec 20181:12 pmRNSTotal Voting Rights
27th Dec 20184:41 pmRNSSecond Price Monitoring Extn
27th Dec 20184:35 pmRNSPrice Monitoring Extension
13th Dec 20189:43 amRNSDirectorate Change
3rd Dec 201810:09 amRNSTotal Voting Rights
19th Nov 201810:11 amRNSDirector Declaration
9th Nov 201811:56 amRNSDirectorate Change
31st Oct 201812:18 pmRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSQ3 2018: Trading Update
1st Oct 20185:17 pmRNSDirector/PDMR Shareholding
1st Oct 201812:34 pmRNSTotal Voting Rights
31st Aug 20184:46 pmRNSTotal Voting Rights
31st Aug 20184:00 pmRNSDirectorate Change
8th Aug 20182:32 pmRNSHolding(s) in Company
1st Aug 20189:43 amRNSTotal Voting Rights
27th Jul 20187:00 amRNSHalf Year Results
2nd Jul 201810:01 amRNSTotal Voting Rights
26th Jun 201810:15 amRNSDirectorate Change
7th Jun 20184:55 pmRNSDirector/PDMR Shareholding
1st Jun 201811:28 amRNSTotal Voting Rights
31st May 20184:35 pmRNSPrice Monitoring Extension
29th May 20183:11 pmRNSDirector/PDMR Shareholding
25th May 20185:34 pmRNSDirector/PDMR Shareholding
9th May 20182:00 pmRNSHolding(s) in Company
8th May 20182:00 pmRNSDirector/PDMR Shareholding
4th May 20184:27 pmRNSDirectorate Change
3rd May 20183:17 pmRNSResult of AGM
1st May 20181:00 pmRNSChange in Director's Details
1st May 20189:30 amRNSTotal Voting Rights
20th Apr 20187:00 amRNSQ1 2018 Trading Update
18th Apr 20182:00 pmRNSHolding(s) in Company
3rd Apr 20189:00 amRNSTotal Voting Rights
28th Mar 20185:23 pmRNSAnnual Financial Report
22nd Mar 20187:00 amRNSOffer Talks Terminated
19th Mar 201811:00 amRNSDirectorate Change
1st Mar 201810:59 amRNSTotal Voting Rights
19th Feb 20187:00 amRNSFinal Results
1st Feb 20189:19 amRNSTotal Voting Rights
2nd Jan 201810:07 amRNSTotal Voting Rights
1st Dec 201710:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.